Tvardi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TVRD and other ETFs, options, and stocks.About TVRD
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
TVRD Key Statistics
Stock Snapshot
Tvardi Therapeutics(TVRD) stock is priced at $3.76, giving the company a market capitalization of 35.27M. It carries a P/E multiple of -0.38.
On 2026-02-13, Tvardi Therapeutics(TVRD) stock moved within a range of $3.76 to $3.76. With shares now at $3.76, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading volume for Tvardi Therapeutics(TVRD) stock has reached 983, versus its average volume of 64.06K.
Over the past 52 weeks, Tvardi Therapeutics(TVRD) stock has traded between a high of $43.65 and a low of $3.50.
Over the past 52 weeks, Tvardi Therapeutics(TVRD) stock has traded between a high of $43.65 and a low of $3.50.
Analyst ratings
50%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.